NCT03123094View on ClinicalTrials.gov

Single Rising Dose Trial of Spesolimab (BI 655130) for Healthy Japanese Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 16, 2017

Primary Completion Date

January 4, 2018

Study Completion Date

January 4, 2018

Conditions
Healthy
Interventions
DRUG

Spesolimab

single dose

DRUG

Placebo

single dose

Trial Locations (1)

47392

Inje University Busan Paik Hospital, Busan

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY